Proinsulin C-Peptide (55-89), human结构式
|
常用名 | Proinsulin C-Peptide (55-89), human | 英文名 | Proinsulin C-Peptide (55-89) human |
---|---|---|---|---|
CAS号 | 11097-48-6 | 分子量 | 3616.99000 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C153H259N49O52 | 熔点 | N/A | |
MSDS | 美版 | 闪点 | N/A |
Proinsulin C-Peptide (55-89), human用途Proinsulin C-Peptide (55-89), human 是人胰岛素原裂解产物的多肽片段。 |
英文名 | Proinsulin connecting peptide |
---|---|
英文别名 | 更多 |
分子式 | C153H259N49O52 |
---|---|
分子量 | 3616.99000 |
精确质量 | 3614.91000 |
PSA | 1646.18000 |
LogP | 0.02050 |
危险品运输编码 | NONH for all modes of transport |
---|---|
WGK德国 | 3 |
Molecular and cellular effects of C-peptide--new perspectives on an old peptide.
Exp. Diabesity Res. 5 , 15-23, (2004) New results present C-peptide as a biologically active peptide hormone in its own right. Although C-peptide is formed from proinsulin and cosecreted with insulin, it is a separate entity with biochemi... |
|
Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein.
Diabetologia 53 , 1761-71 , (2010) Endothelial cells (ECs) and smooth muscle cells (SMCs) play key roles in the development of intimal hyperplasia in saphenous vein (SV) bypass grafts. In diabetic patients, insulin administration contr... |
|
Studies on human proinsulin. Isolation and amino acid sequence of the human pancreatic C-peptide.
J. Biol. Chem. 246 , 1375, (1971)
|
Insulin C chain |
C-Peptide human |
Proinsulin C-Peptide (55-89) human |
C-PEPTIDE (1-35),HUMAN |
Proinsulin (31-65), human |